Vincent Zucconi’s Post

The global RNA Transcriptomics market was valued at USD 5.76 Billion in 2023 and is expected to grow at a CAGR of 11.8% from 2024 to 2031. The market is set for rapid expansion, driven by is a growing demand for personalized or precision medicines, increased investment in pharmaceutical and biotechnology research, increased use of RNA sequencing, high prevalence of gene mutations in cancer and genetic variations, and ongoing developments in medical infrastructure. 🚀 Based on Technology, the Microarray segment is expected to grow at a CAGR of 13.0%.  🌏 The market in Asia-Pacific region is expected to register a fast revenue growth rate with a CAGR of 13.9%. 🎯 Key players includes Thermo Fisher Scientific, Illumina, Roche, Danaher Corporation, Agilent Technologies, Affymetrix, Eurofins, CD Genomics, Bio-Rad Laboratories, Pacific Bio, Promega Corporation , and Others. Latest Development: ⭐ On 08 July 2024, Biostate AI, a scalable biodata foundry firm, has emerged from stealth with the release of two service products: Total RNA sequencing and Copilot for RNAseq data interpretation. Biostate AI intends to engage and collaborate with academic researchers, hospital biorepositories, and pharmaceutical and biotech companies, leveraging its breakthrough technologies for scalable multiomic data collecting, scientific discovery, and AI training. 📧 Feel free to reach out for a complimentary sample report. For more details, please DM or email us at navistrat@outlook.com. #RNAAnalysis #Sequencing #Reversetranscription #Geneexpression #precisionmedicine #drugdiscovery #qPCR #microarray #Proteinexpression #peptides #healthcare #NGS #proteinanalysis #transcriptionprofilling #introns #exons #cancer #genemutations #biomarkers #vaccine #

𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐃𝐫𝐢𝐯𝐞 𝐌𝐢𝐜𝐫𝐨𝐚𝐫𝐫𝐚𝐲 𝐊𝐢𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐨𝐰𝐚𝐫𝐝𝐬 $𝟐.𝟓𝟏 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐌𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞 𝐛𝐲 𝟐𝟎𝟑𝟏 » 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://lnkd.in/eYSy4m6E The #microarray_kits_market is on track to reach a valuation of $2.51 billion by 2031, according to the latest findings from Meticulous Research®. The market is expected to grow at a CAGR of 5.8% from 2024 to 2031, driven by multiple factors. The expanding application of microarrays in diverse research fields, particularly in cancer research, is a major influence. Microarrays facilitate the identification of gene expression patterns, which are crucial for developing effective #cancer_treatments. Additionally, the rising focus on personalized medicine is shaping the landscape of healthcare, with #microarrays serving as vital tools for tailoring treatments to individual genetic profiles. This shift is bolstered by increasing research and development expenditures in the #pharmaceutical and #biotechnology sectors, which are enhancing the demand for advanced microarray kits.   » 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck Group, PerkinElmer, QIAGEN N.V., Edvotek Inc, Sakura Finetek Europe , Dextra Group, GeneCopoeia.   » 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 : • 𝗡𝗲𝘂𝗿𝗼𝗺𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/durzqeWc • 𝗩𝗲𝘁𝗲𝗿𝗶𝗻𝗮𝗿𝘆 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/dV2HS5Xx • 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/d4tRZYXH   #MicroarrayKits #GenomicResearch #BiotechInnovation #DNAAnalysis #GeneExpression #MolecularDiagnostics #HighThroughputScreening #OmicsTechnology #PersonalizedMedicine #CancerResearch #PharmaceuticalDevelopment #Bioinformatics #LaboratoryEquipment #ResearchTools #BiologicalSciences #GenomeMapping #MicroarrayTechnology #ClinicalResearch #GeneticTesting #LifeS ciences

Genomics Market : Use of genomics in specialized /personalized medicine Download PDF Brochure: https://lnkd.in/dX55bjiw Growth in the personalized medicine market is set to offer an array of opportunities for players operating in the market. Various pharmaceutical companies are increasingly investing in personalized medicine research. Personalized medicine enables medical practitioners to identify the exact needs of a patient and then prescribe medicines and treatments accordingly. This approach guarantees better care outcomes. Moreover, it is expected that advancements in the field of gene therapy have the potential to replace traditional drugs and surgeries by enabling doctors to treat a disorder by inserting a gene into a patient’s cell. In September 2022, QIAGEN (Germany) and Neuron23 Inc. (US), an early-stage biotechnology company engaged in developing #precisionmedicine for genetically defined #neurological and #immunological diseases, entered into an agreement to develop a companion diagnostic for Neuron23’s brain penetrant leucine-rich repeat kinase (LRRK2) inhibitor for Parkinson’s disease. In May 2022, Illumina (US) announced a long-term strategic partnership with Janssen to accelerate the development of precision medicine. Through this partnership, Illumina will support drug discovery with whole-genome sequencing (WGS) and other multi-omic methodologies using Illumina Lab Services. Such developments are indicative of the significant opportunities related to the use of NGS in precision medicine and molecular diagnostics. #genomics #personalizedmedicine #geneticresearch #genomesequencing #bioinformatics

"𝐖𝐡𝐞𝐫𝐞 𝐂𝐞𝐥𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐌𝐞𝐞𝐭𝐬 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧" 🧬🎯 | IndustryARC™ Single-Cell Analysis market size was estimated at USD 4.34 billion in 2023 and is projected to grow at a CAGR of 18.7% from 2024 to 2030. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐍𝐨𝐰: 👉 https://lnkd.in/gPUfQdUC   Single-cell analysis allows the study of cell-to-cell variation within a cell population (organ, tissue, and cell culture). Single-cell analysis is the study of genomes, transcriptomics, proteomics, and metabolomics at the single-cell level, and it is used in cancer research and the treatment of a variety of chronic and infectious disorders. It is useful for revealing population, identifying market sub-populations of interest, uncovering unique traits of individual cells, and discovering heterogeneity.   Advances in whole-genome and whole-transcriptome amplification have permitted the gene expression profiling and sequencing of the minute amounts of DNA and RNA present in a single cell, offering a window into the extent and nature of genomic and transcriptomic heterogeneity which occurs in both normal development and disease.   Each cell in the body has a unique genomic structure, which allows the reconstruction of cell lineage trees with very high precision that can predict the existence of small population of steam cells. This information is important for cancer research for detection of rare tumor cells, preimplantation, and genetic diagnosis.   The use of single-cell technology is greatly advancing our understanding of the gut microbiome. Single cell sequencing of microbial cells has the potential to identify specific functions of gut bacteria, providing insights into how the complex variation of microbial strains influences disease.    By Cell Type - Animal Cells - Microbial Cells - Human Cells    By Technique - Flow Cytometry - Next-Generation Sequencing - Polymerase Chain Reaction, Microscopy - Mass Spectrometry   𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: CVS Health | McKesson | Cigna Healthcare Group | Cardinal Health | The Janssen Pharmaceutical Companies of Johnson & Johnson | Sinopharm Group Company Limited | Roche | HCA Healthcare UK | Merck Group | Pfizer | AbbVie | Bayer | Sanofi | AstraZeneca | Novartis |Bristol Myers Squibb | Thermo Fisher Scientific | Abbott | Shanghai IVEN Pharmatech Engineering Co., Ltd #technology #development #future #technique #nextgeneration #humancell #PCR #flowcytometry #singlecell #genetic #DNA #RNA #sequencing #microbiome #biology

𝗖𝗥𝗜𝗦𝗣𝗥 𝗮𝗻𝗱 𝗖𝗮𝘀 𝗚𝗲𝗻𝗲𝘀: 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗚𝗲𝗻𝗼𝗺𝗲 𝗘𝗱𝗶𝘁𝗶𝗻𝗴 CRISPR and Cas genes are transforming the field of #genome engineering by offering precise, efficient, and versatile gene-editing tools. Products such as Vector-based Cas and DNA-free Cas enable researchers to manipulate genetic material with unparalleled accuracy. These technologies are widely used in developing #disease models, advancing functional #genomics, and exploring gene knockdown/activation applications, making them indispensable in modern #biotechnology and genetic research. 𝐒𝐚𝐦𝐩𝐥𝐞 𝐓𝐎𝐂: https://lnkd.in/gNPGJnKt The impact of CRISPR extends across multiple industries. Biotechnology and pharmaceutical companies are leveraging this technology for drug discovery and development, while academic and government research institutes are pushing the boundaries of scientific knowledge. Contract research organizations (CROs) are also playing a pivotal role in facilitating large-scale CRISPR research, accelerating innovation in personalized medicine and therapeutic interventions. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/gesB9cvh With ongoing advancements, CRISPR technology holds immense promise for addressing complex genetic diseases, enhancing agricultural productivity, and even exploring novel approaches in bioengineering. As regulatory frameworks evolve, the future of CRISPR-driven breakthroughs looks brighter than ever, bringing us closer to solving some of the world's most pressing challenges. CRISPR genome editing by IDT Novartis Gene Therapies Gene Solutions Cell Genesys Daan Gene Co., Ltd. Steriline #CRISPR #GenomeEditing #CasGenes #Biotechnology #Pharmaceuticals #FunctionalGenomics #GeneKnockdown #AcademicResearch #GovernmentResearch #ContractResearchOrganizations #GeneticEngineering #PrecisionMedicine #GeneTherapy #InnovationInScience

𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐆𝐞𝐧𝐨𝐦𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐃𝐫𝐢𝐯𝐞 𝐄𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧 𝐢𝐧 𝐭𝐡𝐞 𝐌𝐢𝐜𝐫𝐨𝐚𝐫𝐫𝐚𝐲 𝐊𝐢𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 » 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://lnkd.in/eQdfsNEf The #microarray_kits_market is on track to reach a valuation of $2.51 billion by 2031, according to the latest findings from Meticulous Research®. The market is expected to grow at a CAGR of 5.8% from 2024 to 2031, driven by multiple factors. The expanding application of microarrays in diverse research fields, particularly in cancer research, is a major influence. Microarrays facilitate the identification of gene expression patterns, which are crucial for developing effective #cancer_treatments. Additionally, the rising focus on personalized medicine is shaping the landscape of healthcare, with #microarrays serving as vital tools for tailoring treatments to individual genetic profiles. This shift is bolstered by increasing research and development expenditures in the #pharmaceutical and #biotechnology sectors, which are enhancing the demand for advanced microarray kits.   » 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck Group, PerkinElmer, QIAGEN N.V., Edvotek Inc, Sakura Finetek Europe , Dextra Group, GeneCopoeia.   » 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 : • 𝗡𝗲𝘂𝗿𝗼𝗺𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/durzqeWc • 𝗩𝗲𝘁𝗲𝗿𝗶𝗻𝗮𝗿𝘆 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/dV2HS5Xx • 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/d4tRZYXH   #MicroarrayKits #GenomicResearch #BiotechInnovation #DNAAnalysis #GeneExpression #MolecularDiagnostics #HighThroughputScreening #OmicsTechnology #PersonalizedMedicine #CancerResearch #PharmaceuticalDevelopment #Bioinformatics #LaboratoryEquipment #ResearchTools #BiologicalSciences #GenomeMapping #MicroarrayTechnology #ClinicalResearch #GeneticTesting #LifeS ciences

🗣 Exciting discussion with Dr. Sharon (Sharon Benzeno) from Adaptive Biotechnologies Corp. on the future of biotechnology at the #FierceBiotechSummit 2023. Generative biology is revolutionizing scientific progress by combining AI and ML with innovations in biology. From identifying T-cell signatures to breakthroughs in drug discovery, the potential for improving treatments for cancer, autoimmune disorders, and neurodegenerative diseases is limitless. The key? Scale, speed, and cost efficiency. The future of drug discovery looks bright! 🔗Full Interview: https://lnkd.in/gHx5Nm3T 💡 Join us at the Fierce Biotech Summit 2024 on September 30 - October 1, 2024 in Boston, MA! Click the link below to be a part of our mailing list and be the first to know when registration will open: https://lnkd.in/ewhc9xFk ❗ Stay updated on all our events by following Fierce Life Sciences Events #WeAreFierce #FierceBiotechSummit #FierceBiotech #Biotech #Science #Innovation #BiotechInnovation #DrugDiscovery #GenerativeBiology #HealthTech #AIinHealthcare #MachineLearning

𝐌𝐢𝐜𝐫𝐨𝐚𝐫𝐫𝐚𝐲 𝐊𝐢𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐀𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐞𝐬 𝐓𝐨𝐰𝐚𝐫𝐝 $𝟐.𝟓𝟏 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐕𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏 » 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://lnkd.in/ekFbq-ZZ The #microarray_kits_market is on track to reach a valuation of $2.51 billion by 2031, according to the latest findings from Meticulous Research®. The market is expected to grow at a CAGR of 5.8% from 2024 to 2031, driven by multiple factors. The expanding application of microarrays in diverse research fields, particularly in cancer research, is a major influence. Microarrays facilitate the identification of gene expression patterns, which are crucial for developing effective #cancer_treatments. Additionally, the rising focus on personalized medicine is shaping the landscape of healthcare, with #microarrays serving as vital tools for tailoring treatments to individual genetic profiles. This shift is bolstered by increasing research and development expenditures in the #pharmaceutical and #biotechnology sectors, which are enhancing the demand for advanced microarray kits.   » 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck Group, PerkinElmer, QIAGEN N.V., Edvotek Inc, Sakura Finetek Europe , Dextra Group, GeneCopoeia.   » 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 : • 𝗡𝗲𝘂𝗿𝗼𝗺𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/durzqeWc • 𝗩𝗲𝘁𝗲𝗿𝗶𝗻𝗮𝗿𝘆 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/dV2HS5Xx • 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/d4tRZYXH   #MicroarrayKits #GenomicResearch #BiotechInnovation #DNAAnalysis #GeneExpression #MolecularDiagnostics #HighThroughputScreening #OmicsTechnology #PersonalizedMedicine #CancerResearch #PharmaceuticalDevelopment #Bioinformatics #LaboratoryEquipment #ResearchTools #BiologicalSciences #GenomeMapping #MicroarrayTechnology #ClinicalResearch #GeneticTesting #LifeS ciences

Knowledge is power! 🌟 Stay ahead of the curve with insights into the latest market trends, regulatory updates, and scientific breakthroughs in the rapidly evolving biopharma landscape. The more informed you are, the better equipped you'll be to navigate advancements like enhanced CRISPR techniques and AI-driven drug discovery. Sharpen your skills in this dynamic industry! 💡 Explore specialized courses on platforms like Coursera, edX, and LinkedIn Learning covering biopharma, regulatory affairs, and clinical development. Stay updated on emerging fields like digital health integration and nanomedicine for a competitive edge. Embrace a mindset of growth and exploration in your career journey! 🚀 Innovate and contribute to groundbreaking therapies such as personalized cancer vaccines and microbiome-based treatments. See this path as an opportunity to drive transformative changes in healthcare. Nexus Alliance Biopharma is seeking leaders to propel us to new heights in bispecific ADC, cell and gene therapy, and stem cell endeavors. 🌱 Join us in shaping the future of biopharma and making a difference in healthcare innovation! #Biopharma #HealthcareInnovation #CareerGrowth

𝐄𝐱𝐩𝐚𝐧𝐝𝐢𝐧𝐠 𝐁𝐢𝐨𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐜𝐬 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐏𝐫𝐨𝐩𝐞𝐥 𝐌𝐢𝐜𝐫𝐨𝐚𝐫𝐫𝐚𝐲 𝐊𝐢𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐭𝐨 $𝟐.𝟓𝟏 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏 » 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://lnkd.in/e5MMPj9w The #microarray_kits_market is on track to reach a valuation of $2.51 billion by 2031, according to the latest findings from Meticulous Research®. The market is expected to grow at a CAGR of 5.8% from 2024 to 2031, driven by multiple factors. The expanding application of microarrays in diverse research fields, particularly in cancer research, is a major influence. Microarrays facilitate the identification of gene expression patterns, which are crucial for developing effective #cancer_treatments. Additionally, the rising focus on personalized medicine is shaping the landscape of healthcare, with #microarrays serving as vital tools for tailoring treatments to individual genetic profiles. This shift is bolstered by increasing research and development expenditures in the #pharmaceutical and #biotechnology sectors, which are enhancing the demand for advanced microarray kits.   » 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck Group, PerkinElmer, QIAGEN N.V., Edvotek Inc, Sakura Finetek Europe , Dextra Group, GeneCopoeia.   » 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 : • 𝗡𝗲𝘂𝗿𝗼𝗺𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/durzqeWc • 𝗩𝗲𝘁𝗲𝗿𝗶𝗻𝗮𝗿𝘆 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/dV2HS5Xx • 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/d4tRZYXH   #MicroarrayKits #GenomicResearch #BiotechInnovation #DNAAnalysis #GeneExpression #MolecularDiagnostics #HighThroughputScreening #OmicsTechnology #PersonalizedMedicine #CancerResearch #PharmaceuticalDevelopment #Bioinformatics #LaboratoryEquipment #ResearchTools #BiologicalSciences #GenomeMapping #MicroarrayTechnology #ClinicalResearch #GeneticTesting #LifeS ciences